We believe these data underscore the potential of CagriSema to address unmet medical needs in obesity and support long-term disease management." The NDA is based on results from REDEFINE 1, a 68-week, phase 3, randomized, double-blind, placebo-and active-controlled trial that evaluated the efficacy and safety of once-weekly CagriSema compared to semaglutide 2.4 mg alone, cagrilintide 2.4 mg alone, or placebo, all as an adjunct to lifestyle intervention in 3,417 adults with obesity (BMI 30 kg/m 2 ) or overweight (BMI 27 kg/m 2 ) with one or more obesity-related complications and without diabetes, and REDEFINE 2, a double-blind, randomized, placebo-controlled, 68-week, phase 3 trial that evaluated the efficacy and safety of once-weekly CagriSema versus placebo, as an adjunct to lifestyle intervention in 1,206 adults with type 2 diabetes and either obesity (BMI 30 kg/m 2 ) or overweight (BMI 27 kg/m 2 )
For the past 4 years, Lilys role has included meeting with our guests after each visit and answering any additional questions, as well as, educating them on the importance of lifestyle changes and supplementation
Higher glutathione levels are associated with better heart health and lower risk of heart disease
They are not clinically standardized
Oxidative stress has been studied in the context of severe mental disorders
A peptide blend combines two or more therapeutic peptides that may complement each other to achieve multiple goals at once such as fat loss, muscle growth, tissue repair, and hormone support
